Founded in 2013, Chief Pharma is a high-tech enterprise, focusing on the research and development, production and sales of active pharmaceutical ingredients (APIs) and intermediates. We're featured with Rifamycin series products, specializing in the production of Rifamycin S, Rifampicin, Rifaximin, Rifabutin, Rifamycin Sodium and other products in a large scale. USDMFs and CEPs for Rifamycin series products have already been submitted, and registration in Europe, USA and other countries and regions has been completed.

Our headquarter is located in Luohe City, Henan Province, the hinterland of the central plains. We're committed to the research, development and production of APIs and intermediates in the field of anti-tuberculosis, anti-virus, cardiovascular and diabetes, as well as enzyme production technology in commercial production.